Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 6894675, 8 pages
https://doi.org/10.1155/2017/6894675
Research Article

Histological and Pathological Assessment of miR-204 and SOX4 Levels in Gastric Cancer Patients

1Department of General Surgery, The Fourth Affiliated Hospital of Anhui Medical University, Hefei 230022, China
2Department of Gastrointestinal Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China

Correspondence should be addressed to Wenbin Wang; moc.361@65290022oahin and A-Man Xu; moc.361@uxnama

Received 16 August 2016; Revised 15 November 2016; Accepted 29 November 2016; Published 4 January 2017

Academic Editor: Atif A. Ahmed

Copyright © 2017 Xiao Yuan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Isomoto, S. Shikuwa, N. Yamaguchi et al., “Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study,” Gut, vol. 58, no. 3, pp. 331–336, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Siegel, C. Desantis, and A. Jemal, “Colorectal cancer statistics, 2014,” CA Cancer Journal for Clinicians, vol. 64, no. 2, pp. 104–117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Wang, G.-P. Sun, Y.-F. Zou, J.-Q. Hao, F. Zhong, and W.-J. Ren, “MicroRNAs as promising biomarkers for gastric cancer,” Cancer Biomarkers, vol. 11, no. 6, pp. 259–267, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Cervantes, D. Roda, N. Tarazona, S. Roselló, and J. A. Pérez-Fidalgo, “Current questions for the treatment of advanced gastric cancer,” Cancer Treatment Reviews, vol. 39, no. 1, pp. 60–67, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Zhang, X. Wang, and P. Chen, “MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells,” BMC Cancer, vol. 13, article no. 290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. L. D. Zheng, J. R. Pu, T. Qi et al., “miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells,” Molecular Cancer Research, vol. 11, no. 2, pp. 182–193, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Li, L. Zhai, C. Zhao, and S. Lv, “miR-153 inhibits epithelial–mesenchymal transition by targeting metadherin in human breast cancer,” Breast Cancer Research and Treatment, vol. 150, no. 3, pp. 501–509, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. You, Y. Zhang, B. Liu et al., “MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1,” Indian Journal of Cancer, vol. 51, no. 7, pp. 77–81, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Zhang, F. Huang, J. Wang, L. Peng, and H. Luo, “MiR-15b mediates liver cancer cells proliferation through targeting BCL-2,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 12, pp. 15677–15683, 2015. View at Google Scholar
  10. J. Gong, Z. Cui, L. Li et al., “MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7,” Tumor Biology, vol. 36, no. 10, pp. 7831–7840, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Zhang, Y. Yin, Y. Hu et al., “MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A,” Medical Oncology, vol. 32, no. 1, p. 331, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. L. He and G. J. Hannon, “MicroRNAs: small RNAs with a big role in gene regulation,” Nature Reviews Genetics, vol. 5, no. 7, pp. 522–531, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Liu, H. Xue, J. Zhang et al., “MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression,” Journal of Experimental and Clinical Cancer Research, vol. 34, no. 1, article no. 35, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Li, H. Li, R. Zhang, J. Liu, and J. Liu, “MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer,” Cellular Physiology and Biochemistry, vol. 35, no. 5, pp. 2033–2042, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Du, L. Wang, H. Wu, Y. Zhang, K. Wang, and D. Wu, “MicroRNA-141 inhibits migration of gastric cancer by targeting zinc finger E-box-binding homeobox 2,” Molecular Medicine Reports, vol. 12, no. 3, pp. 3416–3422, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Ma, H. Song, B. Guo et al., “MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1,” Oncotarget, vol. 6, no. 19, pp. 17404–17416, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Lu, Z. Xu, M. Zhang, and Y. Zuo, “MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 10, pp. 7286–7296, 2014. View at Google Scholar · View at Scopus
  18. X. Zhou, W. Jin, H. Jia, J. Yan, and G. Zhang, “MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7,” Journal of Experimental & Clinical Cancer Research, vol. 34, no. 1, article 28, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Zhang, Y. Li, L. Fan et al., “microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo,” Experimental and Therapeutic Medicine, vol. 9, no. 5, pp. 1617–1622, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Guo, Y. Zhang, Y. Zhang et al., “Decreased expression of MIR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer,” International Journal of Molecular Medicine, vol. 36, no. 6, pp. 1720–1726, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Sun, X. Yu, and Q. Bai, “miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 10, pp. 12775–12783, 2015. View at Google Scholar
  22. L. Zhang, X. Wang, and P. Chen, “MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells,” BMC Cancer, vol. 13, article 290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Liu, J. Long, R. du, C. Ge, K. Guo, and Y. Xu, “miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer,” Tumor Biology, vol. 37, no. 6, pp. 8327–8335, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Zhou, L. Li, J. Su, and G. Zhang, “Decreased miR-204 in H. pylori-associated gastric cancer promotes cancer cell proliferation and invasion by targeting SOX4,” PLOS ONE, vol. 9, no. 7, Article ID e101457, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Bilir, A. O. Osunkoya, W. G. Wiles et al., “SOX4 is essential for prostate tumorigenesis initiated by PTEN ablation,” Cancer Research, vol. 76, no. 5, pp. 1112–1121, 2016. View at Publisher · View at Google Scholar
  26. C.-M. Lin, C.-L. Fang, Y.-C. Hseu et al., “Clinical and prognostic implications of transcription factor SOX4 in patients with colon cancer,” PLoS ONE, vol. 8, no. 6, Article ID e67128, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Li, L. Zu, Y. Wang, M. Wang, P. Chen, and Q. Zhou, “miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4,” Journal of Thoracic Disease, vol. 7, no. 9, pp. 1563–1569, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Shen, M. Blijlevens, N. Yang et al., “Sox4 expression confers bladder cancer stem cell properties and predicts for poor patient outcome,” International Journal of Biological Sciences, vol. 11, no. 12, pp. 1363–1375, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. C.-L. Fang, Y.-C. Hseu, Y.-F. Lin et al., “Clinical and prognostic association of transcription factor SOX4 in gastric cancer,” PLoS ONE, vol. 7, no. 12, Article ID e52804, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Wu, H. Pan, Y. Zhou et al., “Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4,” Molecular Medicine Reports, vol. 12, no. 5, pp. 7059–7064, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. J. J. Yin, B. Liang, and X. R. Zhan, “MicroRNA-204 inhibits cell proliferation in T-cell acute lymphoblastic leukemia by down-regulating SOX4,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 8, pp. 9189–9195, 2015. View at Publisher · View at Google Scholar
  32. J. Kang, J. K. Perry, V. Pandey et al., “Artemin is oncogenic for human mammary carcinoma cells,” Oncogene, vol. 28, no. 19, pp. 2034–2045, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Tan, K. Ding, R. Li et al., “Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2,” Breast Cancer Research, vol. 16, no. 2, article no. R40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. Z.-Y. Ding, G.-N. Jin, W. Wang et al., “Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma,” Hepatology, vol. 60, no. 5, pp. 1620–1636, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S. B. Edge and C. C. Compton, “The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM,” Annals of Surgical Oncology, vol. 17, no. 6, pp. 1471–1474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. H. A. Edmondson and P. E. Steiner, “Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies,” Cancer, vol. 7, no. 3, pp. 462–503, 1954. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Qian, Z. Zuo, Z. Wu et al., “Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis,” Cancer Research, vol. 71, no. 20, pp. 6463–6474, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Giatromanolaki, E. Sivridis, A. Mitrakas et al., “Autophagy and lysosomal related protein expression patterns in human glioblastoma,” Cancer Biology & Therapy, vol. 15, no. 11, pp. 1468–1478, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. T. K. H. Chung, T. S. Lau, T. H. Cheung et al., “Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1,” International Journal of Cancer, vol. 130, no. 5, pp. 1036–1045, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. O. Mikhaylova, Y. Stratton, D. Hall et al., “VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma,” Cancer Cell, vol. 21, no. 4, pp. 532–546, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Van De Wetering, M. Oosterwegel, K. Van Norren, and H. Clevers, “Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes,” The EMBO Journal, vol. 12, no. 10, pp. 3847–3854, 1993. View at Google Scholar · View at Scopus
  42. G.-D. Song, Y. Sun, H. Shen, and W. Li, “SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients,” Tumor Biology, vol. 36, no. 6, pp. 4167–4173, 2015. View at Publisher · View at Google Scholar · View at Scopus